Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --4件: 6, 14, 51, 53
210% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14
310% liquid formulation of human immunoglobulin----1件: 14
4: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14
5Act-HiB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 14, 61, 62, 222
6Acthar1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222
7Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14
8Anti-C5 antibody----4件: 11, 14, 62, 109
9Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
10ARGX-113----5件: 11, 14, 35, 53, 63
11ARGX-117----1件: 14
12ARGX-117 IV----1件: 14
13Batoclimab1件: Batoclimab1件: D11983 1件: FCGRT 💬-2件: 11, 14
14Batoclimab 340 mg SC weekly1件: Batoclimab1件: D11983 1件: FCGRT 💬-2件: 11, 14
15Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly1件: Batoclimab1件: D11983 1件: FCGRT 💬-1件: 14
16Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14
17BIVV020----2件: 14, 61
18Carmustine1件: Carmustine1件: D00254 --5件: 11, 13, 14, 28, 60
19Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
20Clorfenamina1件: Chlorpheniramine1件: D07398 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14
21CLORFENAMINA MALEATO1件: Chlorpheniramine1件: D07398 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14
22Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331
23Cytarabine1件: Cytarabine1件: D00168 --7件: 11, 13, 14, 25, 49, 60, 65
24Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
25Drug:----3件: 14, 46, 113
26ECULIZUMAB1件: Eculizumab1件: D03940 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222
27EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: D11876 1件: FCGRT 💬-6件: 11, 14, 35, 53, 63, 162
28Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162
29Efgartigimod PH20 SC in stage B----1件: 14
30Etoposide1件: Etoposide1件: D00125 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331
31FAMPRIDINE1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
32FAMPYRA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
33Fibrinogen1件: Fibrinogen human---2件: 14, 65
34Fibrinogen concentrate1件: Fibrinogen human---1件: 14
35FINGOLIMOD1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156
36FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
37Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45
38FTY720----2件: 13, 14
39FTY720I----1件: 14
40Gammanorm----2件: 14, 65
41Gilenya----3件: 2, 13, 14
42GILENYA 0,5 mg cápsulas duras1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14
43Group C meningococcal conjugate vaccine----1件: 14
44H.P. Acthar® Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14
45HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14
46Haemophilus type b vaccine (conjugated)----1件: 14
47HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46
48Hematopoietic Stem Cell Transplantation----12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285
49Hidrocloruro de fingolimod1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
50Hizentra----4件: 14, 50, 51, 65
51Hizentra®1件: Human immunoglobulin G---2件: 14, 65
52HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65
53Human normal 10% immunoglobulin for intravenous administration1件: Human immunoglobulin G---1件: 14
54Human normal 10% immunoglobulin for intravenous administrationn1件: Human immunoglobulin G---1件: 14
55Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65
56HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65
57Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65
58Human normal immunoglobulin (SCIg)1件: Human immunoglobulin G---1件: 14
59Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65
60Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65
61Hyaluronidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--5件: 14, 28, 51, 65, 331
62HyQvia1件: Hyaluronidase (human recombinant)---2件: 14, 65
63I10----1件: 14
64I10E----3件: 14, 63, 65
65IGIV, 10%----2件: 14, 65
66IgPro10----3件: 14, 51, 65
67IgPro20----4件: 14, 50, 51, 65
68IgPro20 (high dose)----1件: 14
69IgPro20 (low dose)----1件: 14
70IGVENA*FL 200ML 10G+SET----2件: 14, 50
71Immune globulin----3件: 11, 13, 14
72Immune Globulin 10% Intravenous Solution----1件: 14
73Immune Globulin Intravenous (human), 10%----2件: 14, 65
74Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14
75Immune Globulin Subcutaneous (Human)----2件: 14, 65
76Immunoglobulin----3件: 13, 14, 63
77IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65
78Immunoglobulin perfusion----1件: 14
79IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----1件: 14
80Immunoglobuline G----1件: 14
81Immunoglobulins----1件: 14
82Immunoglobulins, normal human, for extravascular adm.----1件: 14
83Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15
84Intratect----4件: 13, 14, 35, 65
85Intravenous immune globulin G----1件: 14
86Intravenous Immunoglobulin----7件: 13, 14, 35, 38, 39, 51, 309
87Intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---4件: 14, 17, 164, 296
88IQYMUNE----1件: 14
89IVIG1件: Human immunoglobulin G---7件: 11, 13, 14, 17, 50, 51, 65
90J07AH07----1件: 14
91KIOVIG1件: Human immunoglobulin G---2件: 14, 65
92KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65
93Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14
94Lipoic acid1件: Lipoic acid---5件: 2, 5, 13, 14, 20
95MabThera1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
96MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53
97MD1003----5件: 2, 10, 13, 14, 20
98Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
99Menjugate----1件: 14
100Methylprednisolon1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 14, 51, 66
101Methylprednisolon (Solu-Medrol)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
102Methylprednisolone1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
103Methylprednisolone (Solu-Medrol)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
104Metilprednisolone sodio succinato----3件: 13, 14, 56
105N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14
106NewGam----3件: 14, 63, 65
107Nipocalimab1件: Nipocalimab1件: D11666 1件: FCGRT 💬-6件: 11, 14, 46, 49, 53, 61
108NPB-01----3件: 13, 14, 162
109PANZYGA----1件: 14
110PARACETAMOLO----9件: 2, 11, 14, 19, 28, 53, 61, 63, 300
111Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
112PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14
113PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
114Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
115Prevenar 131件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---5件: 13, 14, 46, 96, 222
116Prevenar 13 sospensione per iniezione1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 14
117PRIVIGEN1件: Human immunoglobulin G---4件: 11, 14, 51, 65
118Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65
119Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: D04455 ,
D04456 ,
D06604 		--3件: 14, 28, 65
120RHuPH20----2件: 13, 14
121RITUXIMAB1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
122Rituximab (genetical recombination)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 14
123ROZANOLIXIZUMAB1件: Rozanolixizumab1件: D12182 1件: FCGRT 💬-3件: 11, 14, 63
124RVG 51680----1件: 14
125RVG 56083----1件: 14
126SAR445088 (formerly BIVV020)----1件: 14
127SAR445088 (IV)----1件: 14
128SAR445088 (SC)----1件: 14
129Sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --20件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299
130Sodium Chloride 0.9%2件: Chloride ion,
Sodium chloride		1件: D02056 --2件: 14, 227
131SOLIRIS1件: Eculizumab1件: D03940 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222
132SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53
133Subcutaneous immune globulin G----1件: 14
134Subcutaneous immunoglobulin----1件: 14
135Subcuvia----3件: 14, 49, 65
136TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14
137TAK-771----2件: 14, 65
138Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---4件: 13, 14, 46, 50
139TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14
140UCB7665----3件: 11, 14, 63
141VACCINO PNEUMOCOCCICO SACCARIDICO----1件: 14
142Vivaglobin----2件: 14, 65